FFCP PHASE1:Mm9::chr10:46317735..46317745,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=18 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr10:46317735..46317745,+ | |||
|description=CAGE_peak_at_chr10:46317735..46317745,+ | |description=CAGE_peak_at_chr10:46317735..46317745,+ | ||
|id=chr10:46317735..46317745,+ | |id=chr10:46317735..46317745,+ | ||
|ontology_enrichment_celltype=CL:0000553!6.30e-34!6;CL:0000556!6.30e-34!6;CL:0000050!7.58e-23!9;CL:0000414!8.33e-19!11;CL:0000839!5.30e-16!13;CL:0000945!1.16e-13!1;CL:0000236!1.16e-13!1;CL:0000826!1.16e-13!1;CL:0000763!4.21e-13!16;CL:0002031!6.83e-13!25;CL:0000049!4.11e-11!19;CL:0000988!3.85e-10!32;CL:0002032!3.85e-10!32;CL:0000037!3.85e-10!32;CL:0000566!3.85e-10!32;CL:0000837!3.85e-10!32;CL:0002320!3.97e-07!46;CL:0000134!3.97e-07!46 | |ontology_enrichment_celltype=CL:0000553!6.30e-34!6;CL:0000556!6.30e-34!6;CL:0000050!7.58e-23!9;CL:0000414!8.33e-19!11;CL:0000839!5.30e-16!13;CL:0000945!1.16e-13!1;CL:0000236!1.16e-13!1;CL:0000826!1.16e-13!1;CL:0000763!4.21e-13!16;CL:0002031!6.83e-13!25;CL:0000049!4.11e-11!19;CL:0000988!3.85e-10!32;CL:0002032!3.85e-10!32;CL:0000037!3.85e-10!32;CL:0000566!3.85e-10!32;CL:0000837!3.85e-10!32;CL:0002320!3.97e-07!46;CL:0000134!3.97e-07!46 | ||
|ontology_enrichment_celltype_v019_2=CL:0000553,2.03e-33,6;CL:0000556,2.03e-33,6;CL:0000050,1.19e-22,9;CL:0000839,5.32e-16,13;CL:0000763,3.50e-13,16;CL:0000049,3.01e-11,19;CL:0002031,9.29e-09,25;CL:0002027,1.59e-08,3;CL:0002006,1.59e-08,3;CL:0002024,1.59e-08,3;CL:0000988,5.08e-07,32;CL:0002032,5.08e-07,32;CL:0000037,5.08e-07,32;CL:0000837,5.08e-07,32 | |||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001962!1.80e-25!2;UBERON:0001961!1.80e-25!2;UBERON:0001744!1.80e-25!2;UBERON:0002465!2.33e-17!3;UBERON:0003199!8.69e-14!1;UBERON:0002371!4.21e-13!16;UBERON:0001474!1.17e-09!22;UBERON:0004765!1.17e-09!22;UBERON:0001434!1.17e-09!22;UBERON:0002193!1.33e-09!48;UBERON:0002384!3.97e-07!46;UBERON:0002204!9.13e-07!32 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0003199,1.39e-22,1;UBERON:0002371,3.50e-13,16;UBERON:0001962,5.17e-12,2;UBERON:0001961,5.17e-12,2;UBERON:0001744,5.17e-12,2;UBERON:0001474,7.78e-10,22;UBERON:0004765,7.78e-10,22;UBERON:0001434,7.78e-10,22;UBERON:0002465,1.88e-08,3;UBERON:0002193,4.46e-08,48;UBERON:0002405,4.46e-08,48;UBERON:0002204,5.08e-07,32 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.21485160433896,0,2.5236973228659,4.11343300817216,0.42438965179803,0,0,0,0.319984845586813,1.14704640533585,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838913030288682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.21485160433896,0,2.5236973228659,4.11343300817216,0.42438965179803,0,0,0,0.319984845586813,1.14704640533585,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838913030288682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr10:46317735..46317745,+ | |short_description=p@chr10:46317735..46317745,+ | ||
}} | }} |
Latest revision as of 10:21, 4 August 2015
Short description: | p@chr10:46317735..46317745, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:46317735..46317745, + |
Coexpression cluster: | MCL_coexpression_mm9:18 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 2.03e-33 | 6 |
megakaryocyte | 2.03e-33 | 6 |
megakaryocyte-erythroid progenitor cell | 1.19e-22 | 9 |
myeloid lineage restricted progenitor cell | 5.32e-16 | 13 |
myeloid cell | 3.50e-13 | 16 |
common myeloid progenitor | 3.01e-11 | 19 |
hematopoietic lineage restricted progenitor cell | 9.29e-09 | 25 |
CD9-positive, CD41-positive megakaryocyte cell | 1.59e-08 | 3 |
Kit-positive, CD34-negative megakaryocyte erythroid progenitor cell | 1.59e-08 | 3 |
Kit-positive megakaryocyte progenitor cell | 1.59e-08 | 3 |
hematopoietic cell | 5.08e-07 | 32 |
hematopoietic oligopotent progenitor cell | 5.08e-07 | 32 |
hematopoietic stem cell | 5.08e-07 | 32 |
hematopoietic multipotent progenitor cell | 5.08e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
egg chamber | 1.39e-22 | 1 |
bone marrow | 3.50e-13 | 16 |
gut-associated lymphoid tissue | 5.17e-12 | 2 |
mucosa-associated lymphoid tissue | 5.17e-12 | 2 |
lymphoid tissue | 5.17e-12 | 2 |
bone element | 7.78e-10 | 22 |
skeletal element | 7.78e-10 | 22 |
skeletal system | 7.78e-10 | 22 |
lymphoid system | 1.88e-08 | 3 |
hemolymphoid system | 4.46e-08 | 48 |
immune system | 4.46e-08 | 48 |
musculoskeletal system | 5.08e-07 | 32 |